Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Tanezumab

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New Data on TrkA-NAM ACD137 in Knee Osteoarthritis at Pain Meet
    New Data on TrkA-NAM ACD137 in Knee Osteoarthritis at Pain Meet

    05 Aug 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/new-scientific-data-with-trka-nam-acd137-against-knee-osteoarthritis-1056561

    ACCESSWIRE
    05 Aug 2025
    Share Share
    Lilly, Pfizer stop study of arthritis drug after FDA rejection
    Lilly, Pfizer stop study of arthritis drug after FDA rejection

    27 Oct 2021

    // N.P. Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/lilly-pfizer-stop-development-osteoarthritis-drug-after-fda-rejection-extending-bleak-run

    N.P. Taylor FIERCEBIOTECH
    27 Oct 2021
    Share Share
    Lilly Reports Robust Third-Quarter 2021 Financial Results
    Lilly Reports Robust Third-Quarter 2021 Financial Results

    25 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-reports-robust-third-quarter-2021-financial-results-as-pipeline-success-strengthens-future-growth-potential-301408065.html

    PRNEWSWIRE
    25 Oct 2021
    Share Share
    Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer
    Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer

    23 Sep 2021

    // Nick Paul Taylor RAPS

    https://www.raps.org/news-and-articles/news-articles/2021/9/euro-roundup-chmp-recommends-drugs-from-biogen-and

    Nick Paul Taylor RAPS
    23 Sep 2021
    Share Share
    US FDA accepts regulatory submission of Pfizer & Eli Lilly's tanezumab
    US FDA accepts regulatory submission of Pfizer & Eli Lilly's tanezumab

    03 Mar 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=121575&sid=2

    PHARMABIZ
    03 Mar 2020
    Share Share
    U.S. FDA Accepts Regulatory Sub for Tanezumab, a Potential First-in-Class
    U.S. FDA Accepts Regulatory Sub for Tanezumab, a Potential First-in-Class

    02 Mar 2020

    // PRESS RELEASE

    https://investor.lilly.com/news-releases/news-release-details/us-fda-accepts-regulatory-submission-tanezumab-potential-first

    PRESS RELEASE
    02 Mar 2020
    Share Share